News
Teva UK launches GoResp Digihaler
Teva UK has launched GoResp Digihaler across the UK. Containing budesonide and formoterol, the inhaler supports appropriate individuals presenting with asthma and chronic obstructive pulmonary disease (COPD).
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Teva UK has launched GoResp Digihaler across the UK. Containing budesonide and formoterol, the inhaler supports appropriate individuals presenting with asthma and chronic obstructive pulmonary disease (COPD).